Pasar al contenido principal
U.S. flag

An official website of the United States government

Here’s how you know

.gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Clinicalinfo.HIV.gov logo.
En afiliación con HIV.gov
Main navigation
  • Inicio
  • Sobre Clinicalinfo
  • Guías
  • Medicamentos
  • Glosario
  • Noticias
  • Recursos
  • Contáctenos
  • Español (Spanish)
  • English
  1. Inicio
  2. Guidelines search

Búsqueda de Guías

  • Perinatal HIV Clinical Guidelines (41)
  • (-) HIV Clinical Guidelines: Adult and Adolescent ARV (36)
  • HIV Clinical Guidelines: Pediatric ARV (36)
  • HIV Clinical Guidelines: Adult and Adolescent Opportunistic Infections (14)
  • HIV Clinical Guidelines: Pediatric Opportunistic Infections (6)
  • Guidance for Caring for People With HIV Displaced by Disasters (2)
Resultados de la búsqueda 21 – 36 de 36
Cardiovascular Complications in People With HIV
… of a first MACE with ART regimens, including ABC versus tenofovir-containing regimens, 33 and an increased MACE … (HDL), and triglycerides have been observed with tenofovir alafenamide (TAF), efavirenz (EFV), all boosted … who received TAF when compared with those who received tenofovir disoproxil fumarate (TDF) in multiple randomized …
Weight Gain in People With Treated HIV
… reverse transcriptase inhibitor (NNRTI)–based and tenofovir disoproxil fumarate (TDF)–based regimens. 6-9 … and the nucleotide reverse transcriptase inhibitor (NRTI) tenofovir alafenamide (TAF), 11,13 especially when compared … . Lake JE, Trevillyan J. Impact of Integrase inhibitors and tenofovir alafenamide on weight gain in people with HIV. …
Special Populations: Adolescents and Young Adults With HIV
… regimens. Bictegravir (BIC) coformulated with tenofovir alafenamide (TAF) and emtricitabine (FTC) also has … risk of side effects, such as bone and renal toxicity with tenofovir-based drugs in rapidly growing adolescents. These … peak bone mass, TAF generally should be used instead of tenofovir disoproxil fumarate, because of a greater bone …
Special Populations: Early (Acute and Recent) HIV Infection
… ARV regimens is recommended b (AIII): Bictegravir (BIC)/tenofovir alafenamide (TAF)/emtricitabine (FTC) Dolutegravir (DTG) with (TAF or tenofovir disoproxil fumarate [TDF]) c plus (FTC or … of the INSTI genotype. c TAF and TDF are two forms of tenofovir that are approved in the United States. TAF has …
Special Populations: HIV-2 Infection
… controlled trial comparing raltegravir (RAL) plus tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) to … D, Gallien S, et al. First-line raltegravir/emtricitabine/tenofovir combination in human immunodeficiency virus type 2 … regimen of elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for the initial treatment of …
Special Populations: HIV and the Older Person
… to the marked fracture risk. ART regimens that contain tenofovir disoproxil fumarate (TDF), 27 boosted protease … (INSTIs). 28-31 Abacavir (ABC), NRTI-sparing regimens, and tenofovir alafenamide (TAF) may be considered as … density after initiation of antiretroviral treatment with tenofovir disoproxil fumarate/emtricitabine plus …
Special Populations: Substance Use Disorders and HIV
… with HBV/HIV coinfection unless HBV-active drugs (i.e., tenofovir, entecavir) are included in the regimen. Because … in an urban safety-net HIV clinic reported increases in tenofovir-reactive urine tests and stimulant-negative urine …
Special Populations: Transplantation in People With HIV
… and efficacy of the new regimen before transplant (BIII). Tenofovir alafenamide (TAF) is preferred over tenofovir disoproxil fumarate (TDF) in transplant candidates … = raltegravir; RPV = rilpivirine; RTV = ritonavir; TDF = tenofovir disoproxil fumarate; TDM = therapeutic drug …
Hepatitis B Virus/HIV Coinfection
… be stopped in people with HBV/HIV (AII).  Before Initiating Tenofovir-Sparing Antiretroviral Regimens People with HIV … should have their HBV status verified before initiating a tenofovir-sparing ARV regimen. See  Optimizing … must be given if the selected ARV regimen does not contain tenofovir (AII).  TAF or TDF are preferred for HBV treatment …
Hepatitis C Virus/HIV Coinfection
… HBV = hepatitis B virus; HCV = hepatitis C virus; TAF = tenofovir alafenamide; TDF = tenofovir disoproxil fumarate The treatment of hepatitis C … HBV (positive HBsAg) should receive ART that includes tenofovir alafenamide or tenofovir disoproxil fumarate, or …
Tuberculosis/HIV Coinfection
… or clinically suspected INSTI resistance) (AIII). Tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) (AIII), tenofovir alafenamide (TAF)/FTC (BIII), or abacavir … DTG dosing (AII). When prescribing either 1HP or 3HP, tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) …
Special Populations: Women With HIV
… by HIV and some ARV drugs. 19-22 ARV regimens that contain tenofovir disoproxil fumarate (TDF), boosted protease … a 12.3­kg weight gain was recorded among women receiving tenofovir alafenamide (TAF)/emtricitabine (FTC)/DTG compared … Two small studies showed no difference in plasma levels of tenofovir and RAL between pre- and postmenopausal women. …
Cost Considerations and Antiretroviral Therapy
… during the 2026 and 2027 cycles, Biktarvy (bictegravir/tenofovir alafenamide/emtricitabine) has been selected for … established clinical safety and efficacy, such as generic tenofovir disoproxil fumarate (TDF), which has been … of generic TDF-based regimens versus branded tenofovir alafenamide (TAF)–based regimens. 62 The study …
Drug-Drug Interactions
… = rilpivirine; RTV = ritonavir; SQ = subcutaneous; TAF = tenofovir alafenamide; TDF = tenofovir disoproxil fumarate; UGT = uridine diphosphate … pharmacokinetics of atazanavir-ritonavir with or without tenofovir in HIV-infected patients. AIDS Patient Care STDS . …
Appendix A. Drug Characteristics Tables
… Dosing Recommendation a INSTI Plus Two NRTIs Bictegravir/Tenofovir Alafenamide/Emtricitabine (BIC/TAF/FTC) Biktarvy … 300 mg One tablet PO once daily Elvitegravir/Cobicistat/Tenofovir Alafenamide/Emtricitabine (EVG/c/TAF/FTC) Genvoya … One tablet PO once daily with food Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine (EVG/c/TDF/FTC) …
Appendix C: Drug Name Abbreviations
… RTV or r ritonavir SQV saquinavir T-20 enfuvirtide TAF tenofovir alafenamide TDF tenofovir disoproxil fumarate TFV tenofovir TFV-DP tenofovir-diphosphate TMP-SMX …

Paginación

  • Primera página ‹‹
  • Página anterior ‹
  • Página 1
  • Página actual 2

Conéctese con nosotros

Footer menu

  • Inicio
  • Sobre Clinicalinfo
  • Guías
  • Medicamentos
  • Glosario
  • Noticias
  • Recursos
  • Contáctenos
  • Patrocinadores
  • Aviso de no discriminación
  • Accesibilidad
  • El descargo de responsabilidad
  • Mapa del sitio
  • Declaración de privacidad
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Ley de Acceso a Información

Proporcionado en colaboración con la Oficina de Investigación del SIDA de los NIH.